SEC Info - Annovis Bio, Inc. - ‘25’ on 11/26/21

SEC Info℠

Home

Help

Please Sign In

Annovis Bio, Inc. – ‘25’ on 11/26/21

On: Friday, 11/26/21, at 11:43am ET · Effective: 11/26/21 · Accession #: 1104659-21-143846 · File #: 1-39202

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

11/26/21  Annovis Bio, Inc.                 25         11/26/21    1:11K                                    Toppan Merrill/FA

Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities — Form 25

Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 25          Notice by an Issuer of the Removal from Listing     HTML      8K 
                and Registration on a Securities Exchange of                     
                Matured, Redeemed or Retired Securities

Filing Submission 0001104659-21-143846 – SGML Text

Original SGML Text submitted by:	Toppan Merrill/FA (as Filing Agent)

⇓Show all <DOCUMENT> <TEXT> elements below – 11K ↑Top ↓Bottom

<SUBMISSION>
<SECARCHIVE-DATETIME>		20220319-152504	 ⇐ Metadata from SEC Info (ET)
<SECWEBSITE-DATETIME>		20211126-114612	 ⇐ Metadata from SEC Info (ET)
<ACCEPTANCE-DATETIME>		20211126-114328	 ⇐ Filing accepted by SEC (ET)
<ACCESSION-NUMBER>		0001104659-21-143846
<TYPE>				25
<PUBLIC-DOCUMENT-COUNT>		1
<FILING-DATE>			20211126
<DATE-OF-FILING-DATE-CHANGE>	20211126
<EFFECTIVENESS-DATE>		20211126

<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>		Annovis Bio, Inc.
<CIK>				0001477845
<ASSIGNED-SIC>			2834
<IRS-NUMBER>			262540421  ⇒ 26-2540421 or 262-54-0421
<STATE-OF-INCORPORATION>	DE
<FISCAL-YEAR-END>		1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>			25
<ACT>				34
<FILE-NUMBER>			001-39202
<FILM-NUMBER>			211450452
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>			1055 WESTLAKES DRIVE, SUITE 300
<CITY>				BERWYN
<STATE>				PA
<ZIP>				19312
<PHONE>				610-727-3913
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>			1055 WESTLAKES DRIVE, SUITE 300
<CITY>				BERWYN
<STATE>				PA
<ZIP>				19312
</MAIL-ADDRESS>
<FORMER-COMPANY>
<FORMER-CONFORMED-NAME>		QR Pharma, Inc.
<DATE-CHANGED>			20091202
</FORMER-COMPANY>
</FILER>

<DOCUMENT>
<TYPE>		25
<SEQUENCE>	1
<FILENAME>	tm2133952d1_25.htm
<DESCRIPTION>	25
<TEXT>
<HTML>
       Show <HTML>: 158 lines (widest: 324 characters) - 10K bytes  
</TEXT>
</DOCUMENT>

</SUBMISSION>

↑Top

Filing Submission 0001104659-21-143846 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Annovis Bio, Inc. – ‘25’ on 11/26/21

On: Friday, 11/26/21, at 11:43am ET · Effective: 11/26/21 · Accession #: 1104659-21-143846 · File #: 1-39202

Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities — Form 25Filing Table of Contents

Notice by an Issuer of the Removal from Listing and Registration on a Securities Exchange of Matured, Redeemed or Retired Securities — Form 25

Filing Table of Contents